What do we get when we fuse Spleen cells and Myeloma cells?(a) Hybridoma cells(b) Red blood cells(c) Killer cells(d) Cancer myeloma B-cellThe question was asked in class test.The query is from Genetic Recombination topic in chapter Genetic Recombination of Drug Biotechnology

What do we get when we fuse Spleen cells and Myeloma cells?(a) Hybrido

1.	What do we get when we fuse Spleen cells and Myeloma cells?(a) Hybridoma cells(b) Red blood cells(c) Killer cells(d) Cancer myeloma B-cellThe question was asked in class test.The query is from Genetic Recombination topic in chapter Genetic Recombination of Drug Biotechnology
Answer» RIGHT answer is (a) HYBRIDOMA cells The best I can explain: SPLEEN cells are fused with myeloma cells to get hybridoma cells. The fusion has to be done in PEG. The growth medium has to be FEEDER cells. Plating of the cells should be in HAT medium. Through ELISA we can determine the growth.

Discussion

No Comment Found

Related InterviewSolutions

Bispecific antibodies can bind with their Fab regions both to target antigen and to _____________(a) Other antibodies(b) An effector cell(c) Proteins around(d) ProstaglandinsThe question was posed to me during an interview.This intriguing question originated from Genetic Recombination in section Genetic Recombination of Drug Biotechnology
MAbs was modified for delivery of a toxin, radioisotope and __________(a) Enzymes(b) Hormones(c) Drugs(d) CytokineThis question was posed to me in exam.Query is from Genetic Recombination in division Genetic Recombination of Drug Biotechnology
MAbs act directly when binding to cancer-specific antigens and induce an immunological response to cancer cells.(a) True(b) FalseThis question was addressed to me in an online quiz.This question is from Genetic Recombination in division Genetic Recombination of Drug Biotechnology
What is the clinical application of monoclonal antibodies?(a) Biosensors(b) Transplant rejection(c) Infectious disease(d) Purification of drugsI had been asked this question during an interview.This question is from Genetic Recombination topic in division Genetic Recombination of Drug Biotechnology
Biosensors & Microarrays are diagnostic applications of monoclonal antibodies.(a) True(b) FalseThis question was addressed to me during an internship interview.The above asked question is from Genetic Recombination in chapter Genetic Recombination of Drug Biotechnology
Fight against Bioterrorism is one of the clinical applications of monoclonal antibodies.(a) True(b) FalseI have been asked this question in homework.My doubt is from Genetic Recombination topic in section Genetic Recombination of Drug Biotechnology
Which of the following will perfectly fit in the marked place?(a) Antigen(b) Cells from different organism(c) Spleen cells(d) NK cellsI have been asked this question in quiz.I want to ask this question from Genetic Recombination topic in division Genetic Recombination of Drug Biotechnology
The cell fusion happens between spleen cells and _____________(a) Red blood cells(b) Cancer cell(c) Myeloma cells(d) LeukocytesThis question was posed to me during an interview for a job.Question is from Genetic Recombination in division Genetic Recombination of Drug Biotechnology
For which discovery did Georges Köhler and César Milstein share the noble prize in 1984?(a) Inventing genome sequencing(b) Discovery the structure of DNA(c) Discovery of B-cell cancer myeloma(d) Discovery of the process of producing monoclonal antibodiesI had been asked this question during an online exam.The above asked question is from Genetic Recombination in division Genetic Recombination of Drug Biotechnology
What is the method to harvest monoclonal antibodies from the positive clones?(a) Subculture in the new medium(b) Bioreactors(c) One a single media plate(d) Tissue culture methodThe question was posed to me in an interview.The query is from Genetic Recombination topic in division Genetic Recombination of Drug Biotechnology

What do we get when we fuse Spleen cells and Myeloma cells?(a) Hybridoma cells(b) Red blood cells(c) Killer cells(d) Cancer myeloma B-cellThe question was asked in class test.The query is from Genetic Recombination topic in chapter Genetic Recombination of Drug Biotechnology

Discussion

No Comment Found

Related InterviewSolutions

Reply to Comment